# Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/exercise-endocannabinoid-anxiety-adolescent-treatment-research/ > **Published:** 2026-05-08T15:06:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:06:56-04:00 > **Clinical Summary:** Clinical trial explores how exercise endocannabinoid anxiety treatment works in adolescents through fear extinction and brain circuitry modulation research. --- CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🧪 Clinical Trial Watch  |  CED Clinic Trial ID NCT06297278 Status Recruiting Condition Adolescence Intervention Moderate Intensity Exercise Why This Matters Adolescent [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) represent a critical therapeutic gap, with conventional treatments showing limited efficacy in developing brains. This trial addresses a fundamental need by investigating whether acute exercise can enhance fear extinction through endocannabinoid modulation—potentially offering a novel, accessible intervention for youth anxiety. Clinical Summary This ongoing recruitment-phase trial examines whether moderate-intensity exercise can improve fear extinction learning in adolescents through enhanced frontolimbic brain activity and endocannabinoid signaling. The study focuses on adolescent participants and measures both neurobiological markers and behavioral outcomes related to fear regulation. Investigators are testing the hypothesis that exercise-induced endocannabinoid release can optimize the neural circuits responsible for extinguishing pathological fear responses. Dr. Caplan’s Take “If positive, this trial could establish exercise as a precision medicine tool for adolescent [anxiety treatment](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/), leveraging the endocannabinoid system’s natural capacity for fear regulation. This represents exactly the kind of mechanism-based intervention we need—using endogenous cannabinoid pathways rather than exogenous compounds in developing brains.” Clinical Perspective 🧠 Families seeking [anxiety treatment](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/) for adolescents should know this trial explores a potentially safer alternative to pharmacological interventions during critical brain development periods. Clinicians should monitor this research as it may inform evidence-based exercise prescriptions for [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/), particularly given the endocannabinoid system’s central role in both physical activity and [emotional regulation](https://cedclinic.com/cannabis-for-childrens-behavior/). 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Exercise%20Facilitation%20of%20Adolescent%20Fear%20Extinction%2C%20Frontolimbic%20Circuitry%2C%20and...%20%40drcaplan&url=https%3A//clinicaltrials.gov/study/NCT06297278)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//clinicaltrials.gov/study/NCT06297278)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Exercise%20Facilitation%20of%20Adolescent%20Fear%20Extinction%2C%20Frontolimbic%20Circuitry%2C%20and...%20--%20via%20%40drcaplan.bsky.social%20https%3A//clinicaltrials.gov/study/NCT06297278)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://clinicaltrials.gov/study/NCT06297278](https://clinicaltrials.gov/study/NCT06297278) Table of Contents - [FAQ](#FAQ)[What is this adolescent exercise and fear extinction trial studying?](#What_is_this_adolescent_exercise_and_fear_extinction_trial_studying) - [Is this exercise trial for teens still enrolling participants?](#Is_this_exercise_trial_for_teens_still_enrolling_participants) - [How might exercise affect the endocannabinoid system and fear?](#How_might_exercise_affect_the_endocannabinoid_system_and_fear) - [Why does this trial focus on anxiety in adolescents?](#Why_does_this_trial_focus_on_anxiety_in_adolescents) - [Related](#Related) ## FAQ ### What is this adolescent exercise and fear extinction trial studying? The trial (NCT06297278) is examining whether moderate-intensity exercise can improve fear extinction learning in adolescents. Researchers are looking at whether this happens through enhanced frontolimbic brain activity and endocannabinoid signaling, and they are measuring both neurobiological markers and behavioral outcomes related to fear regulation. ### Is this exercise trial for teens still enrolling participants? Yes. The trial is listed with a status of recruiting and is described as being in its recruitment phase. It focuses on adolescent participants and tests moderate-intensity exercise as the intervention. Because it is ongoing, it is not yet known whether exercise improves fear extinction in this group. ### How might exercise affect the endocannabinoid system and fear? Investigators are testing the hypothesis that exercise-induced release of endocannabinoids can optimize the neural circuits responsible for extinguishing pathological fear responses. This is a hypothesis under study, not an established finding, and the trial is designed to test whether it holds in adolescents. ### Why does this trial focus on anxiety in adolescents? Adolescent [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) are described as a critical therapeutic gap, with conventional treatments showing limited efficacy in developing brains. The trial investigates whether acute exercise can enhance fear extinction through endocannabinoid modulation, which could potentially offer a novel, accessible intervention for youth anxiety. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).